PharmaRadar360

PharmaRadar360

🇯🇵·4h agoResearch

ミルベツキシマブ ソラブタンシン(遺伝子組換え)製剤の使用に当たっての留意事項について(厚生労働省)

Publisher

J
Japanese Society of Medical Oncology

Japan

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Japanese Society of Medical Oncology
Region
Japan
Scope
Research
Published
September 16, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on jsmo.or.jp

Leave the platform to read the original full article on the publisher site.

Source: Japanese Society of Medical Oncology

Scope: Research

Open original article
ミルベツキシマブ ソラブタンシン(遺伝子組換え)製剤の使用に当たっての留意事項について(厚生労働省) | PharmaRadar360